Results 61 to 70 of about 77,862 (256)

H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study. [PDF]

open access: yesPLoS ONE, 2011
BACKGROUND: The guidelines recommend that first line treatment of chronic spontaneous urticaria should be second generation non-sedating H(1)-antihistamines with a positive recommendation against the use of old sedating first generation antihistamines ...
Karsten Weller   +8 more
doaj   +1 more source

Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia

open access: yesDrugs in Context, 2022
Urticaria is a disabling condition, resulting in an impaired quality of life and sleep disruption, and can have an adverse impact on work-related or school-related performance and attendance.
Wai Kwong Cheong   +9 more
doaj   +1 more source

Impact of Chronic Urticaria on Major Life‐Changing Decisions: Greater Burden in Social, Physical, and Job/Career Domains

open access: yesJEADV Clinical Practice, EarlyView.
The 32‐item Major Life‐Changing Decision Profile was validated and applied to 111 Turkish‐speaking chronic urticaria patients. Overall, 79.3% reported at least one affected major life‐changing decision, most commonly in social (69.4%), physical (56.8%) and job/career (36.9%) domains. Higher impact was observed in patients with disease onset ≤ 45 years (
Sinem Ornek Ozdemir   +15 more
wiley   +1 more source

Chronic urticaria and thyroid pathology

open access: yesWorld Allergy Organization Journal, 2020
Urticaria is defined as the sudden appearance of erythematous, itchy wheals of variable size, with or without angioedema (AE) (swelling of the deeper layers of the skin). Its classification depends on time course of symptoms and the presence of eliciting
Sandra Nora Gonzalez-Diaz   +5 more
doaj   +1 more source

Remibrutinib in chronic spontaneous urticaria: 52-Week results from two phase 3 studies.

open access: yesJournal of Allergy and Clinical Immunology
BACKGROUND Remibrutinib, an oral, highly selective Bruton's tyrosine kinase inhibitor, demonstrated significant improvements in disease activity over placebo in the 24-week phase 3 REMIX studies in patients with chronic spontaneous urticaria remaining ...
A. Giménez-Arnau   +21 more
semanticscholar   +1 more source

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit   +5 more
wiley   +1 more source

H1-antihistamines for chronic spontaneous urticaria [PDF]

open access: yesCochrane Database of Systematic Reviews, 2014
Background Chronic spontaneous urticaria (CSU) is characterised by the development of crops of red, itchy, raised weals or hives with no identifiable external cause.Objectives To assess the effects of H1-antihistamines for CSU.Search methods We searched the following databases up to June 2014: Cochrane Skin Group Specialised Register, CENTRAL (2014 ...
Maulina, Sharma   +3 more
openaire   +2 more sources

An Overview of Chronic Spontaneous Urticaria: Diagnosis, Management, and Treatment

open access: yesAllergy Asthma and Immunology Research
Chronic spontaneous urticaria (CSU) is a complex mast cell-driven disorder characterized by recurrent pruritic wheals and/or angioedema lasting over 6 weeks.
Bushra Tbakhi   +4 more
semanticscholar   +1 more source

BTK signaling - a crucial link in the pathophysiology of chronic spontaneous urticaria.

open access: yesJournal of Allergy and Clinical Immunology, 2023
Chronic spontaneous urticaria (CSU) is an inflammatory skin disorder that manifests with itchy wheals, angioedema, or both for >6 weeks. Mast cells (MCs) and basophils are the key pathogenic drivers of CSU; their activation results in histamine and ...
J. Bernstein, Marcus Maurer, S. Saini
semanticscholar   +1 more source

Learner Agency and the Negotiation of EFL Motivation in GenAI‐Mediated Drama‐Based Learning: A Qualitative Case Study

open access: yesTESOL Quarterly, EarlyView.
Abstract The rapid integration of generative artificial intelligence (GenAI) is reshaping language learning environments, yet little is known about how it becomes embedded within learners' motivational and agentive experiences in collaborative, informal settings like English drama‐based learning.
Meng Xiong, Timothy Teo
wiley   +1 more source

Home - About - Disclaimer - Privacy